Pediatrix Medical Group (MD) Competitors $16.97 +0.82 (+5.10%) Closing price 03:59 PM EasternExtended Trading$17.00 +0.03 (+0.19%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. CRVL, AMED, AMN, CCRN, LH, DGX, DVA, CHE, BLCO, and SHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include CorVel (CRVL), Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Bausch + Lomb (BLCO), and Sotera Health (SHC). Pediatrix Medical Group vs. Its Competitors CorVel Amedisys AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics DaVita Chemed Bausch + Lomb Sotera Health Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends. Do institutionals and insiders hold more shares of MD or CRVL? 97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.9% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 44.6% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, MD or CRVL? Pediatrix Medical Group has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, CorVel has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Is MD or CRVL more profitable? CorVel has a net margin of 10.98% compared to Pediatrix Medical Group's net margin of 5.66%. CorVel's return on equity of 32.31% beat Pediatrix Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group5.66% 18.94% 7.10% CorVel 10.98%32.31%18.33% Does the media refer more to MD or CRVL? In the previous week, Pediatrix Medical Group had 2 more articles in the media than CorVel. MarketBeat recorded 12 mentions for Pediatrix Medical Group and 10 mentions for CorVel. CorVel's average media sentiment score of 1.65 beat Pediatrix Medical Group's score of 1.12 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer MD or CRVL? Pediatrix Medical Group currently has a consensus price target of $16.75, suggesting a potential downside of 1.31%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Pediatrix Medical Group is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.57CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings and valuation, MD or CRVL? CorVel has lower revenue, but higher earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$2.01B0.73-$99.07M$1.2913.16CorVel$895.59M5.31$95.17M$1.9447.75 SummaryCorVel beats Pediatrix Medical Group on 9 of the 17 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.48B$7.74B$5.82B$21.16BDividend YieldN/A2.64%3.84%3.59%P/E Ratio13.1678.4731.1529.14Price / Sales0.7330.39474.7754.98Price / Cash9.2324.8637.1523.84Price / Book1.7717.069.115.45Net Income-$99.07M$243.33M$3.26B$992.10M7 Day Performance6.21%1.08%2.12%2.62%1 Month Performance33.03%0.80%5.13%2.51%1 Year Performance54.02%13.93%31.25%13.06% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group2.094 of 5 stars$16.97+5.1%$16.75-1.3%+48.4%$1.48B$2.01B13.164,305News CoveragePositive NewsAnalyst RevisionCRVLCorVel2.1485 of 5 stars$87.47+1.5%N/A-13.9%$4.42B$895.59M45.095,075News CoveragePositive NewsInsider TradeAMEDAmedisys3.1505 of 5 stars$100.97+0.0%$100.50-0.5%+3.2%$3.32B$2.35B39.2919,000Short Interest ↑AMNAMN Healthcare Services4.4921 of 5 stars$16.46-4.6%$30.25+83.8%-61.5%$660.03M$2.98B-2.122,968CCRNCross Country Healthcare3.3584 of 5 stars$12.67-0.4%$17.93+41.5%-3.3%$416.73M$1.34B-48.738,205LHLabcorp4.7833 of 5 stars$267.72+0.7%$289.58+8.2%+20.9%$22.09B$13.01B29.5570,000Positive NewsDGXQuest Diagnostics4.5258 of 5 stars$178.29+0.7%$186.00+4.3%+20.0%$19.79B$9.87B21.3556,000News CoveragePositive NewsInsider TradeDVADaVita4.4992 of 5 stars$129.22-0.2%$164.00+26.9%-8.7%$9.26B$12.82B12.7176,000Positive NewsCHEChemed4.9928 of 5 stars$432.47-0.7%$579.75+34.1%-21.1%$6.34B$2.43B22.2315,695Positive NewsBLCOBausch + Lomb2.2558 of 5 stars$13.66+0.1%$15.56+13.9%-10.1%$4.83B$4.79B-17.5113,500SHCSotera Health1.4147 of 5 stars$14.06+0.6%$16.00+13.8%+3.7%$3.97B$1.10B175.773,000News CoverageHigh Trading Volume Related Companies and Tools Related Companies CRVL Competitors AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors BLCO Competitors SHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access